Project Grant R21AI196787
Award Date 4/13/26
Completion Date 3/31/28
Dollars Obligated $230K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $427,625 to the University of North Carolina at Chapel Hill on July 24, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support research addressing the ethical, legal, and social implications (ELSI) of human viromics research. The grant extends through June 30, 2027, and represents NIAID's commitment to integrating bioethics work with genomic research in...
- Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $229,360 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) awarded on April 15, 2026, with a completion date of March 31, 2028. This exploratory R21 grant funds research investigating the impact of host genetic variants on Chikungunya virus (CHIKV)-induced disease outcomes. The project delivers...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of North Carolina at Chapel Hill a Project Grant totaling $553,779.00 under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 4, 2026, with a completion date of January 31, 2031. This five-year research initiative investigates translation regulation mechanisms during human cytomegalovirus (HCMV) infection, focusing on how infected cells...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of North Carolina at Chapel Hill a Project Grant of $162,000 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 22, 2025, with completion anticipated by July 31, 2027. This award supports investigator-initiated research focused on understanding the mechanisms and parameters controlling gene amplification that leads to phenotypic...
- Federal Project Grant Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of North Carolina at Chapel Hill $420,553 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop novel single-cell measurement technologies and conduct fundamental research on antibiotic tolerance in bacterial populations. The award, effective August 8, 2025 through July 31, 2027, funds the design and implementation of a single-cell technique capable...
- Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $233,250 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on May 13, 2025, with completion targeted for April 30, 2027. This award supports the development and characterization of self-circulating non-replicating bacteriophages (SCNRPVs) as a novel gene therapy platform for targeted...
- Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $421,067 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on August 8, 2025, with a completion date of July 31, 2027. This research initiative delivers scientific investigation and experimental research services focused on understanding the mechanisms by which neutrophil extracellular traps...
- Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $2.94 million Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on August 18, 2025, with a completion date of July 31, 2029. This award supports the development and clinical advancement of ACE2 immunodecoys as long-lasting immunoprophylaxis against sarbecoviruses and merbecoviruses that target...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $438,500 Project Grant to the University of California, San Diego under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 8, 2025, with a completion date of June 30, 2027. This award funds investigator-initiated biomedical research examining the sequence-specific determinants and impacts of NS2 (nonstructural protein 2) interactions with the Influenza A Virus...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $115,123 Project Grant to the University of North Carolina at Chapel Hill's Office of Sponsored Research on August 20, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports research titled "Inside Out: Revealing Strategies for Intracellular S. Aureus Persister Eradication," with a completion date of July 31, 2027. The research aims...